32 related news articles for

Faced with a condition that’s rarely spoken about, despite affecting up to 40 percent of all women, Sally decided things had to change, so she volunteered to be our POP advocate – sharing her story and her suffering to help avoid others going through the same thing.…  Read more

This research has the potential to revolutionise therapies for pelvic floor regeneration and enable personalised medicine for women.…  Read more

Every day we are reminded that women’s health conditions don’t receive the funding or priority in medical research that they should. Women are more likely to die from a heart attack, twice as likely to have a hip replacement fail (prosthetic hips have been developed for the male body), more likely to be over medicated (women are frequently excluded from clinical trials) and less likely to have their pain taken seriously.…  Read more

New ways to prevent and cure pelvic organ prolapse (POP) are a big step closer, thanks to major funding for pioneering research at Hudson Institute.…  Read more

Hudson Institute researchers have had some great success in the recent NHMRC Grant rounds.…  Read more

A researcher leading the most exciting project in search of a fix for pelvic organ prolapse (POP) has been awarded a prestigious fellowship to advance her work.…  Read more

Hudson Institute researcher, Dr Shayanti Mukherjee has been placed at Moderna Australia as one of the 2023 recipients of the MTPConnect REDI fellowship.…  Read more

Hudson Institute research into treatments for severe influenza and pelvic organ prolapse have received funding in the Victorian Medical Research Acceleration grants 2023.…  Read more

People living with pelvic organ prolapse (POP) have had a limited number of treatments available to them over the years, so a new POP treatment option can be a cause for excitement.…  Read more

It’s a condition that is rarely spoken about, but one Australian woman has set out to change that – meet Hudson Institute’s new pelvic organ prolapse (POP) advocate, Sally Maconochie.…  Read more

They say prevention is better than cure, but when it comes to pelvic organ prolapse, the specialists at Hudson Institute of Medical Research are taking them equally seriously.…  Read more

Welcome to Hudson News Winter 2022. As I write this, Mother’s Day is fast approaching and we look forward to celebrating and honouring our mothers as well as motherhood in all its forms.…  Read more

Whether it’s working to help women living with the crippling effects of pelvic organ prolapse (POP), end the pain of endometriosis, or even developing new methods of vaginal reconstruction, Professor Gargett is at the forefront.…  Read more

Hudson Institute has featured prominently in the Victorian Premier’s Awards for Health and Medical Research, thanks to pioneering work developing new treatments for pelvic organ prolapse (POP).…  Read more

A researcher developing 3D bioprinted mesh for use in treating pelvic organ prolapse (POP) has received a Victoria Fellowship, allowing him to travel overseas to further his research into bioinks.…  Read more

Hudson Institute researcher, Dr Shayanti Mukherjee, has won the prestigious international Women in STEM2D Scholar Award for her ground-breaking bioengineering work in helping women with pelvic organ prolapse (POP). …  Read more

Six months after the birth of her third child, Jess*, 35, felt something wasn’t right. As she was walking 200 metres to the beach one day with her baby in a carrier, she felt an uncomfortable dragging sensation in her pelvis and had to sit down.…  Read more

Six Early Career Researchers have been chosen for the 2021 Hudson Institute Emerging Leaders program.…  Read more

Pelvic organ prolapse (POP) can be a debilitating condition, predominantly caused by the impact of childbirth. It affects an estimated one in four women, and one in two women over 50.…  Read more

A world-first discovery led by Dr Shayanti Mukherjee has found materials called perovskites—commonly used in solar cells production —have anti-microbial properties, without toxic side effects to human cells.…  Read more

A revolutionary technology to treat pelvic organ prolapse is one step closer after the latest results from a Hudson Institute study.…  Read more

Hudson Institute has had outstanding success in the NHMRC Ideas Grant round.

Our researchers have been awarded nine NHMRC Ideas Grants, totalling almost $8.5 million and a success rate of 19.1 per cent.…  Read more

Hudson Institute scientists have demonstrated a two-step stem cell-based bioengineering approach in a pre-clinical model for the treatment of pelvic organ prolapse (POP).…  Read more

Hudson Institute researchers have pioneered 3D bioprinted degradable meshes with stem cells for the treatment of pelvic organ prolapse (POP), in the hope of providing a safe, effective solution for millions of women worldwide.…  Read more

A safer and more effective treatment for women with pelvic organ prolapse (POP) may be on the horizon, thanks to a new technique that uses a woman’s own stem cells to boost the effectiveness of a degradable mesh. A study published in Biomacromolecules, led by Dr Shayanti Mukherjee, shows how a degradable mesh, made from…  Read more

A discovery that provides deeper understanding about inflammation in the endometrium could bring scientists closer to improving pelvic organ prolapse (POP) treatment for women, a condition resulting from injury during childbirth. Our study, published in the January edition of Reproduction, shows that mesenchymal stem cells (MSC) in the endometrium have the capacity to dampen inflammation.…  Read more

Hudson Institute has had excellent success in the recent NHMRC and ARC Grant rounds.…  Read more

Congratulations to the 2018 Hudson Institute Travel Awards recipients, who will attend international conferences and visiting laboratories to build invaluable knowledge in their area of research. The Awards (supported by donations from the Grisha Sklovsky Memorial Fund and Philip Wind Travel Fund) support six Hudson Institute Postdoctoral Fellows and PhD students to gain experience relevant…  Read more

Hudson Institute of Medical Research scientists are combining stem cells from the lining of a woman’s own uterus with nanobiomaterials (biodegradable materials engineered on the nanoscale) in a world-first approach to develop safer, more effective treatments for pelvic organ prolapse.…  Read more

Renowned stem cell scientist Caroline Gargett has received an academic promotion to Professor from Monash University. Prof Gargett is an NHMRC Senior Research Fellow and heads the Endometrial Stem Cell Biology laboratory in The Ritchie Centre at Hudson Institute. Prof Gargett says she is honoured to receive a promotion for her work which investigates underlying…  Read more

Federal Member for Chisholm and former speaker, Anna Burke, and City of Monash Mayor, Cr Stefanie Perri, toured the Monash Health Translation Precinct’s (MHTP) new $84 million Translational Research Facility yesterday (Monday, February 15).…  Read more

New treatment for millions of women affected by a hidden condition, pelvic organ prolapse (POP), will be the focus of Dr Shayanti Mukherjee’s novel bioengineering project, thanks to a prestigious John Stocker Postdoctoral Fellowship.…  Read more